Showing results (51-60 of 433) with videos related to
Sort By:
Pageof 44
Clinical Trials (London, England)|June 14, 2023
BASIC: A Bayesian adaptive synthetic-control design for phase II clinical trialsLiyun Jiang, Peter F Thall, Fangrong Yan, et al.The International Journal of Biochemistry & Cell Biology|June 6, 2009
MicroRNAs, ultraconserved genes and colorectal cancersSimona Rossi, Scott Kopetz, Ramana Davuluri, et al.Cancers|October 27, 2022
Identification of the O-Glycan Epitope Targeted by the Anti-Human Carcinoma Monoclonal Antibody (mAb) NEO-201Kwong Y Tsang, Massimo Fantini, Anjum Zaki, et al.Nature Reviews. Cancer|January 5, 2017
Consensus molecular subtypes and the evolution of precision medicine in colorectal cancerRodrigo Dienstmann, Louis Vermeulen, Justin Guinney, et al.Cancers|October 13, 2021
Implications of Intratumor Heterogeneity on Consensus Molecular Subtype (CMS) in Colorectal CancerSaikat Chowdhury, Matan Hofree, Kangyu Lin, et al.Acta Oncologica (Stockholm, Sweden)|April 20, 2010
Is there a role for adjuvant therapy in resected adenocarcinoma of the small intestineMichael J Overman, Scott Kopetz, E Lin, et al.Translational Research : the Journal of Laboratory and Clinical Medicine|July 27, 2019
CTC analysis: an update on technological progressIzhar S Batth, Abhisek Mitra, Sierra Rood, et al.Trends in Cancer|May 31, 2024
Advancements in combining targeted therapy and immunotherapy for colorectal cancerManisha Singh, Van Karlyle Morris, Irfan N Bandey, et al.Investigational New Drugs|June 28, 2018
Phase II study of DFP-10917, a deoxycytidine analog, given by 14-day continuous intravenous infusion for chemotherapy-refractory advanced colorectal cancerAmir Mehrvarz Sarshekeh, Henry Q Xiong, Kenzo Iizuka, et al.Current Treatment Options in Oncology|April 25, 2018
Correction to: Accelerating Therapeutic Development through Innovative Trial Design in Colorectal CancerMichael Lam, Jonathan M Loree, Allan Andresson Lima Pereira, et al.Pageof 44